Novo Nordisk has stated that its flagship insulin brand Mixtard will continue to be available in India in vial form, even as the company phases out other delivery formats such as Penfill cartridges.
Pharmaceutical giant Novo Nordisk is discontinuing the country's largest selling insulin, Human Mixtard, along with other insulins. The move could shake up the diabetes market, TOI reported. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback